Carmat Past Earnings Performance

Past criteria checks 0/6

Carmat's earnings have been declining at an average annual rate of -9.2%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 61.7% per year.

Key information

-9.2%

Earnings growth rate

12.1%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate61.7%
Return on equityn/a
Net Margin-5,974.1%
Next Earnings Update11 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Carmat makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:CXT Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 231-54160
31 Mar 231-54150
31 Dec 220-54150
30 Sep 221-58140
30 Jun 222-62140
31 Mar 222-62130
31 Dec 212-62120
30 Sep 211-52120
30 Jun 210-42120
31 Mar 210-40110
31 Dec 200-37100
30 Sep 200-38120
30 Jun 200-40140
31 Mar 200-41130
31 Dec 190-43130
30 Sep 190-45120
30 Jun 190-47120
31 Mar 190-44110
31 Dec 180-42110
30 Sep 180-38100
30 Jun 180-3490
31 Mar 180-3280
31 Dec 170-2970
30 Sep 170-2870
30 Jun 170-2770
31 Mar 170-2570
31 Dec 160-2360
30 Sep 160-2160
30 Jun 160-2060
31 Mar 160-1960
31 Dec 150-1860
30 Sep 150-1760
30 Jun 150-1750
31 Mar 150-1750
31 Dec 140-1850
30 Sep 140-1950
30 Jun 140-2040
31 Mar 141-1740
31 Dec 133-1540
30 Sep 133-1340
30 Jun 133-1140

Quality Earnings: CXT is currently unprofitable.

Growing Profit Margin: CXT is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CXT is unprofitable, and losses have increased over the past 5 years at a rate of 9.2% per year.

Accelerating Growth: Unable to compare CXT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CXT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).


Return on Equity

High ROE: CXT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.